Find similar content

Source channel @githubtrending · Post #15415 · Jan 15

#go#bpf#cncf#cni#containers#ebpf#k8s#kernel#kubernetes#kubernetes_networking#loadbalancing#monitoring#networking#observability#security#troubleshooting#xdp Cilium is an eBPF-based tool for Kubernetes that delivers fast networking, deep visibility, and strong security. It creates simple Layer 3 networks across clusters, handles load balancing to replace kube-proxy, enforces identity-based policies from L3 to L7 (like HTTP or DNS rules), supports service mesh with encryption, and offers Hubble for real-time traffic monitoring. Stable versions like v1.18.6 run on AMD64/AArch64. You gain scalable performance, easier policy management without IP hassles, better troubleshooting, and higher efficiency for large cloud-native apps, cutting costs and boosting reliability. https://github.com/cilium/cilium

Hashtags

#go #bpf #cncf #cni #containers #ebpf #k8s #kernel #kubernetes #kubernetes_networking #loadbalancing #monitoring #networking #observability #security #troubleshooting #xdp

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment